FR2245369A1 - - Google Patents

Info

Publication number
FR2245369A1
FR2245369A1 FR7432265A FR7432265A FR2245369A1 FR 2245369 A1 FR2245369 A1 FR 2245369A1 FR 7432265 A FR7432265 A FR 7432265A FR 7432265 A FR7432265 A FR 7432265A FR 2245369 A1 FR2245369 A1 FR 2245369A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7432265A
Other versions
FR2245369B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2245369A1 publication Critical patent/FR2245369A1/fr
Application granted granted Critical
Publication of FR2245369B1 publication Critical patent/FR2245369B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
FR7432265A 1973-10-01 1974-09-25 Expired FR2245369B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/402,657 US4013665A (en) 1973-10-01 1973-10-01 Antiviral, substituted 1,3-dimethyl-1h-pyrazolo(3,4b)quinolines

Publications (2)

Publication Number Publication Date
FR2245369A1 true FR2245369A1 (fr) 1975-04-25
FR2245369B1 FR2245369B1 (fr) 1978-07-28

Family

ID=23592812

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7432265A Expired FR2245369B1 (fr) 1973-10-01 1974-09-25

Country Status (19)

Country Link
US (1) US4013665A (fr)
JP (1) JPS582948B2 (fr)
BE (1) BE820400A (fr)
CA (1) CA1032538A (fr)
CH (3) CH621552A5 (fr)
CY (1) CY1087A (fr)
DE (1) DE2446821A1 (fr)
DK (1) DK516274A (fr)
ES (1) ES430554A1 (fr)
FI (1) FI57414C (fr)
FR (1) FR2245369B1 (fr)
GB (1) GB1488692A (fr)
HK (1) HK59380A (fr)
KE (1) KE3086A (fr)
MY (1) MY8100219A (fr)
NL (1) NL7412959A (fr)
NO (1) NO143223C (fr)
SE (1) SE419760B (fr)
ZA (1) ZA746138B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848968B (en) * 1983-11-18 1986-06-25 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolines and 1h-imidazo(4,5-c)quinolin-4-amines
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US5332734A (en) * 1991-04-10 1994-07-26 Japan Tobacco, Incorporated Oxazinone derivative
US5608067A (en) * 1993-12-09 1997-03-04 Afonso; Adriano 4-substituted pyrazoloquinoline derivatives
US5506236A (en) * 1994-04-28 1996-04-09 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5786480A (en) * 1994-04-28 1998-07-28 Schering Corporation 4-substituted pyrazoloquinoline derivatives
US5614530A (en) * 1995-03-10 1997-03-25 Sterling Winthrop Inc. Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US6008226A (en) * 1995-03-10 1999-12-28 Sanofi-Synthelabo Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
US5488055A (en) * 1995-03-10 1996-01-30 Sanofi Winthrop Inc. Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
US7084156B2 (en) * 2001-11-27 2006-08-01 Merck & Co., Inc. 2-Aminoquinoline compounds
WO2003045920A1 (fr) * 2001-11-27 2003-06-05 Merck & Co., Inc. Composes 4-aminoquinoleines
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
WO2008010963A2 (fr) * 2006-07-18 2008-01-24 3M Innovative Properties Company Formules modificatrices de la réponse immunitaire
WO2008016475A2 (fr) * 2006-07-31 2008-02-07 3M Innovative Properties Company Compositions à base de modificateurs de la réponse immunitaire et procédés
WO2010062559A1 (fr) * 2008-10-28 2010-06-03 Schering Corporation Pyrazoloquinoléines substituées et leurs dérivés

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1152421B (de) * 1961-03-21 1963-08-08 Bayer Ag Verfahren zur Herstellung von 4-Hydroxy-pyrazolo[3, 4-b]chinolinen
DE1445719A1 (de) * 1961-03-21 1969-01-09 Bayer Ag Verfahren zur Herstellung von 4-Chlor- oder 4-Brom-pyrazolo[3,4-]chinolinen
DE1186867B (de) * 1961-05-03 1965-02-11 Bayer Ag Verfahren zur Herstellung von heterocyclischen Verbindungen
DE1222885B (de) * 1962-05-25 1966-08-18 Bayer Ag Optische Aufhellungsmittel
US3600393A (en) * 1969-03-03 1971-08-17 Aldrich Chem Co Inc Dialkylamino alkylamino pyrazolo (3,4b) quinolines
JPS4826797A (fr) * 1971-08-07 1973-04-09
US3790576A (en) * 1972-03-20 1974-02-05 Parke Davis & Co 9 substituted 4,9-dihydro-1,3,4,4-tetraalkyl-1h-pyrazolo(3,4-b)quinolines

Also Published As

Publication number Publication date
NL7412959A (nl) 1975-04-03
FR2245369B1 (fr) 1978-07-28
CY1087A (en) 1980-12-27
CH621552A5 (fr) 1981-02-13
FI57414C (fi) 1980-08-11
GB1488692A (en) 1977-10-12
JPS5059396A (fr) 1975-05-22
NO143223B (no) 1980-09-22
US4013665A (en) 1977-03-22
KE3086A (en) 1980-11-07
NO143223C (no) 1981-01-02
ES430554A1 (es) 1977-07-01
ZA746138B (en) 1975-10-29
NO743528L (fr) 1975-04-28
CH622793A5 (fr) 1981-04-30
DE2446821A1 (de) 1975-04-10
BE820400A (fr) 1975-03-26
AU7379874A (en) 1976-04-01
JPS582948B2 (ja) 1983-01-19
SE419760B (sv) 1981-08-24
CA1032538A (fr) 1978-06-06
CH619712A5 (fr) 1980-10-15
HK59380A (en) 1980-10-31
SE7412275L (fr) 1975-04-02
MY8100219A (en) 1981-12-31
FI57414B (fi) 1980-04-30
DK516274A (fr) 1975-06-30
USB402657I5 (fr) 1976-04-06
FI281574A (fr) 1975-04-02

Similar Documents

Publication Publication Date Title
AU476761B2 (fr)
AR201231Q (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU471343B2 (fr)
FR2245369B1 (fr)
AU465453B2 (fr)
AU476714B2 (fr)
AU476696B2 (fr)
AU472848B2 (fr)
AU466283B2 (fr)
AU477823B2 (fr)
AU477824B2 (fr)
AU476873B1 (fr)
AR200885A1 (fr)
AU471461B2 (fr)
AU5382473A (fr)
AU479562A (fr)
CH119773A4 (fr)
BG19767A1 (fr)
CH563577A5 (fr)
CH563245A5 (fr)
CH566892A5 (fr)
AU479522A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse